News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TheraGenetics Reports Fourth Quarter and Year-End 2012 Results


2/14/2013 7:06:12 AM

Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the fourth quarter and year ended December 31, 2012.

Consolidated Results

• Consolidated revenue ? $19.1 million in the fourth quarter, down 4% from 2011
? $82.6 million for the year, flat compared with 2011

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES